OTCM
CLABF
Market cap3mUSD
Jul 08, Last price
0.05USD
1D
0.00%
1Q
21.38%
IPO
-99.44%
Name
Core One Labs Inc
Chart & Performance
Profile
Core One Labs Inc. operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents. The company also offers consulting, financing, and micro cultivation services, as well as operates medical and wellness clinics. In addition, it provides natural health products; and news dissemination services. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||
Revenues | 648 50.15% | |||||||
Cost of revenue | 8,516 | |||||||
Unusual Expense (Income) | ||||||||
NOPBT | (7,868) | |||||||
NOPBT Margin | ||||||||
Operating Taxes | 5 | |||||||
Tax Rate | ||||||||
NOPAT | (7,874) | |||||||
Net income | (15,976) -56.88% | |||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 2,260 | |||||||
BB yield | ||||||||
Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
Cash flow | ||||||||
Cash from operating activities | (1,997) | |||||||
CAPEX | (13) | |||||||
Cash from investing activities | 190 | |||||||
Cash from financing activities | 2,610 | |||||||
FCF | (9,828) | |||||||
Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
EV | ||||||||
Common stock shares outstanding | 30,751 | |||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | (7,817) | |||||||
EV/EBITDA | ||||||||
Interest | 5 | |||||||
Interest/NOPBT |